1-1 of 1
Hussain I. Saba, MD, PhD
Close
Sort by
Journal Articles

Response Rates of Phase 2 and Phase 3 Trials of Decitabine (DAC) in Patients with Myelodysplastic Syndromes (MDS).

Hussain I. Saba, MD, PhD, Michael Lùˆbbert, MD, PhD, P.W. Wijermans, MD
Journal: Blood
Blood (2005) 106 (11): 2515.
https://doi.org/10.1182/blood.V106.11.2515.2515
Published: 2005